Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,28437175,Cmax,The mean Cmax was 0.0471 ± 0.0105 ng/mL for patients aged 2 months to <3 years; 0.0258 ± 0.0128 ng/mL for ages 3 to <12 years; and 0.0109 ± 0.0005 ng/mL for ages 12 to <18 years.,Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/28437175/),[ng] / [ml],0.0471,223734,DB00287,Travoprost
,28437175,Cmax,The mean Cmax was 0.0471 ± 0.0105 ng/mL for patients aged 2 months to <3 years; 0.0258 ± 0.0128 ng/mL for ages 3 to <12 years; and 0.0109 ± 0.0005 ng/mL for ages 12 to <18 years.,Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/28437175/),[ng] / [ml],0.0258,223735,DB00287,Travoprost
,28437175,Cmax,The mean Cmax was 0.0471 ± 0.0105 ng/mL for patients aged 2 months to <3 years; 0.0258 ± 0.0128 ng/mL for ages 3 to <12 years; and 0.0109 ± 0.0005 ng/mL for ages 12 to <18 years.,Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/28437175/),[ng] / [ml],0.0109,223736,DB00287,Travoprost
